Simcere Pharmaceutical Group Ltd SMHGF
$1.49
Last Updated: Mar 09, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Simcere Pharmaceutical Group Ltd. Stock Analysis SMHGF
United States Health Care Mid Cap Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. The firm's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The firm also produces various drugs, including Endostar used for oncology. The firm is also involved in providing promotion services for third-party drugs sold by medical institutions. The firm mainly conducts its businesses in the domestic market and overseas markets.
Simcere Pharmaceutical Group Ltd (SMHGF) Chart
Financial Metrics & Statements of Simcere Pharmaceutical Group Ltd (SMHGF)
FAQ's for Simcere Pharmaceutical Group Ltd (SMHGF)
- As of August 2026, Simcere Pharmaceutical Group Ltd SMHGF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Simcere Pharmaceutical Group Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Simcere Pharmaceutical Group Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Simcere Pharmaceutical Group Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Simcere Pharmaceutical Group Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Simcere Pharmaceutical Group Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Simcere Pharmaceutical Group Ltd (SMHGF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
